Delivery Order SPE2DR25D2012-SPE2DR26F1BTR
Award Date 1/15/26
Potential Completion Date 1/16/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,024.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $11,491.49 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with an ultimate completion date of January 16, 2026. The contract utilizes firm fixed price pricing with no set-aside designation, indicating the award was made through full and open competition. Performance of this delivery order will occur at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $31,315.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This non-set-aside award was completed on January 15, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,157.68 on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive, firm fixed-price delivery order is set to be completed by December 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,364.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on June 2, 2025. This firm fixed-price delivery order, which is scheduled for completion by June 3, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle with the DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,268.06 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a $3,214.56 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance will occur at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $2,009.12 and an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12,054.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on December 29, 2025, with completion scheduled for December 30, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,077.99 by the Defense Logistics Agency (DLA) on December 17, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price contract is classified as a child delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. The award represents a continuation of AmerisourceBergen's substantial...